The imminent human trial for cellular reprogramming isn't just about aging; it's about a radical shift in economic power. This is the true story of longevity tech.
The latest breakthroughs in aging science aren't about living forever—they're about extending the profitable middle years. Unpacking the hidden economics of longevity.
The promise of an anti-ageing drug is here, but the true battle isn't biological—it's economic and ethical. Unpacking the impending longevity divide.
MIT scientists claim to rejuvenate the aged immune system. But who truly benefits from this 'longevity hack'?
The promise of reversing grey hair isn't just about vanity; it's a high-stakes battleground for anti-aging breakthroughs and economic control.